Back to Stock Dashboard
Sector:
Financial Services
Add to portfolio
BMEZ
BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust (BMEZ) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Financial Services sector peers. Its strongest pillar is Momentum (A-); its weakest is Profitability (D).
Quantitative Factor Evaluation • Updated
Overall Rating
2.8
/ 5.0
C+
Value
B+
Factor Score
3.8
/ 5.0
Growth
C+
Factor Score
2.5
/ 5.0
Profitability
D
Factor Score
1.5
/ 5.0
Momentum
A-
Factor Score
3.9
/ 5.0
Revisions
C+
Factor Score
2.5
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
5.0
EV / EBITDA
N/A
Rev Growth YoY
N/A
Gross Margin
0.0%
Price Return 3M
5.9%
Price Return 12M
24.2%
Catalyst Signal
0.00
Market Cap
$1.1B
TTM Revenue
N/A
Price / Sales
N/A
ROE
N/A
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | B+ (3.8) | C+ (2.5) | D (1.5) | A- (3.9) | C+ (2.5) | C+ (2.8) |
| 2026-11-10 | B+ (3.8) | C+ (2.5) | D (1.5) | A- (4.1) | C+ (2.5) | B- (2.9) |
| 2026-11-03 | B+ (3.8) | C+ (2.5) | D (1.5) | A (4.2) | C+ (2.6) | B- (2.9) |
| 2026-10-27 | A- (3.9) | C+ (2.5) | D (1.5) | A- (4.1) | C+ (2.5) | B- (2.9) |
| 2026-10-20 | A- (3.9) | C+ (2.5) | D (1.5) | B+ (3.8) | C+ (2.5) | C+ (2.8) |
Page
1
of
4